Background/Aims: The blunted ventricular systolic and diastolic contractile responses to physical and pharmacological stress in cirrhosis are termed cirrhotic cardiomyopathy (CCM). CCM has been known to involve multiple defects in the β-adrenergic signaling pathway. The aim of this study was to determine whether cirrhotic patients have blunted cardiac responses to catecholamine stimulation through dobutamine stress echocardiography (DSE). Methods: Seventy-one cirrhotic patients with normal left ventricular (LV) chamber size and ejection fraction were enrolled. The LV systolic and diastolic functions were evaluated by two-dimensional and Doppler echocardiography at rest and during peak dobutamine infusion (40 μg/kg/min). An abnormal response was defined as a decrease of less than 10% in LV end-diastolic volume, a decrease of less than 20% in end-systolic volume, and an increase of less than 10% in LV ejection fraction (EF) at peak dobutamine infusion, based on previously used criteria. The early/late diastolic flow (E/A) ratio and diastolic parameters were also measured. Results: A blunted LV response to dobutamine was observed in 18 of 71 cirrhotic patients (25.4%). The baseline EF was significantly higher in 18 patients with a blunted DSE response than that of those with a normal DSE response (P<0.05). The baseline and peak E/A ratios, which are common diastolic dysfunction markers, were higher in the cirrhosis group than in the control group (P<0.001). No adverse events associated with DSE were observed. Conclusions: Blunted cardiac responses to dobutamine stimulation, which are implicated in defects in the β-adrenergic signaling pathway, might contribute to the pathogenesis of CCM in patients with cirrhosis. (Korean J Hepatol 2010;16:376-382) 
INTRODUCTION
Coronary artery disease which makes ischemic heart disease or cardiac dysfunction is rare in cirrhosis. 1, 2 However, most patients with cirrhosis have hemodynamic alterations characterized by increased cardiac output and decreased systemic vascular resistance and arterial pressure. 3, 4 Despite the increased resting cardiac output, the ventricular contractile response to stimuli is attenuated, a condition termed cirrhotic cardiomyopathy (CCM). [5] [6] [7] In the absence of consensus definitions, the term 'cirrhotic cardiomyopathy' is defined at present as: 1) baseline increased Although CCM is clinically important, the screening methods and the prevalence of CCM are not clear yet. Many factors are Figure 1 . Mechanism of dobutamine stress echocardiography (DSE) as a screening test for cardiac dysfunction in liver cirrhosis, such as cirrhotic cardiomyopathy (CCM). Heart-cell contractility is determined mainly by the stimulatory β-adrenergic receptor system. When stimulated by norepinephrine or other catecholamines, the β-adrenergic receptor-ligand complex couples with the G-protein to stimulate membrane-bound adenylate cyclase, generating cAMP, which phosphorylates several proteins, leading to intracellular calcium fluxes. The calcium then causes actin-myosin crosslinking, and thus cellular contraction. In CCM, the β-adrenergic receptor signaling pathway shows defects at multiple points, so dobutamine, an adrenergic stimulant, could not induce a myocardial response. βAR, β-adrenergic receptor; AC, adenylate cyclase; NO, nitric oxide; CO, carbon monoxide; iCa, intracellular free calcium-denotes an inhibitory stimulatory influence.
suggested as a mechanism of CCM and impaired β-adrenergic receptor signal transduction is one of them. 8, 9 Hence, we assumed that ventricular systolic and diastolic function in a CCM patient would be blunted by norepinephrine or other catecholamines stimulation such as dobutamine (Fig. 1) . Therefore, in this study, we aimed to evaluate whether cardiac responses to stimulation by catecholamine are blunted in patients with cirrhosis through dobutamine stress echocardiography (DSE). 
MERTERIALS AND METHODS Patients

Dobutamine stress echocardiography (DSE)
Patients and controls were studied the morning after an overnight fasting. After a 30-min period in the supine position, heart rate and arterial pressure were recorded and then DSE was taken. In resting conditions, a two-dimensional echocardiographic examination of the left ventricle was performed using a wide-angle phased-array imaging system (General Electric, case of disagreement, the judgment of a third observer was conclusive.
Definition
An abnormal volume and left ventricular EF response is defined as a blunted DSE response with a less than 10% decrease in end-diastolic volume, a less than 20% decrease in end-systolic volume, and a less than 10% increase in EF at peak dobutamine infusion. 10 We also measured chronotropic response by heart rate (HR) reserve (HRR)={[(peak HR-HR at rest)/(220-age-HR at rest)]×100} and a chronotropic incompetence was defined as HRR less than 80%.
11,12
Variability analysis 
Echocardiographic indices according to DSE outcome
No significant difference in echocardiographic indices at baseline and peak dobutamine infusion between control and cirrhosis patients was observed except baseline and peak E/A ratio. Baseline and peak E/A ratio, common diastolic dysfunction markers, were higher in the cirrhosis group than in controls ( 
Liver profiles according to DSE outcome
There was no significant difference in Child-Pugh score, MELD score, or etiology of cirrhosis between normal and blunted DSE response groups. Hence, no correlation was documented between the severity of cirrhosis and the development of cardiac dysfunction (Table 1) .
Chronotropic incompetence
Including all blunted DSE response patients, 88.6% of the cirrhotic patients showed chronotropic incompetence (HRR less than 80%) for dobutamine infusion. No significant correlation between the severity of chronotropic incompetence and DSE response outcome was observed (P>0.05). However, eight cirrhotic patients who showed paradoxical heart rate responses for dobutamine infusion (HRR less than 0%) also showed blunted DSE response.
DISCUSSION
Cardiac output increases whereas systemic vascular resistance and arterial pressure decrease in cirrhosis. Despite the increased basal cardiac output, the cardiac response to physiologic or pharmacologic stimuli is known to be subnormal, a phenomenon called 'cirrhotic cardiomyopathy' (CCM). [3] [4] [5] [6] [7] Without firm diagnostic criteria and a screening test, the exact prevalence of CCM remains unknown. In general, CCM does not show overt heart failure at rest due to an 'auto-treating' effect reducing afterload related to peripheral vasodilatation of cirrhosis and compensatory diminution of inhibitory influences such as the cardiac muscarinic system. 5, 13 Therefore, in general, CCM is clinically not so problematic in a resting state. However, stresses such as liver transplantation, infection, and procedures like the insertion of TIPS, can convert latent to overt heart failure.
Indeed, with increasing liver transplantation, CCM-related heart failure is the third-leading cause of death after rejection and infection. 7, 14 Therefore, the development of a precise screening test and assessment of CCM severity is necessary in the management of cirrhosis.
Diastolic dysfunction is believed to be present in virtually all CCM patients, and a few reports have suggested that CCM could be diagnosed with simple echocardiographic diastolic dysfunction indices such as the E/A ratio even at rest. Additionally, the E/A ratio has been suggested recently as predictive marker for survival after TIPS. 16 Our study also showed a significant difference in E/A ratio between controls and the total cirrhotic patients group. In addition, baseline and peak E/A ratio increased significantly according to Child-Pugh class as in previous studies, i.e., cirrhotic patients group showed definitive diastolic dysfunction compared with the normal control group. 17 However, in the present study, no significant difference in the severity of diastolic dysfunction was seen between subgroups of cirrhosis according to the DSE response.
15
Many previous studies about diastolic dysfunction of CCM have a limitation because they only compared cirrhosis with normal controls. Diastolic dysfunction could be seen almost old ages.
Indeed, some authorities contend that some degree of diastolic dysfunction is present in virtually every patient with cirrhosis. to use as a provocation test. 15, 22 While some previous studies used dobutamine on cirrhotic patients, it was just used to assess the risk of ischemic heart disease prior to a major operation; it was not proposed to estimate CCM. 23, 24 Heart cell contractility is mainly determined by the stimulatory β-adrenergic receptor system. When stimulated by norepinephrine or other catecholamines, the β-adrenergic receptor-ligand complex couples with G-protein to stimulate membrane-bound adenylate cyclase, generating cAMP which phosphorylates several proteins leading to intracellular calcium fluxes. The calcium then causes actin-myosin cross-linking, and thus cellular contraction. 8, 9 The impairment of such stimulatory β-adrenergic receptor signalling pathways is the main pathogenesis of CCM;
hence we assumed that ventricular systolic and diastolic function in a CCM patient would be blunted by norepinephrine or other catecholamines stimulation such as dobutamine. Cardiac responses to environmental changes are probably even more important than how heart function at rest. Dobutamine is the most commonly used sympathomimetic agent for pharmacologic stress testing through having its effect of direct inotropic stimulation. This study is the first to apply DSE for differentiating CCM from general cirrhosis. We analyzed blunted and normal response cirrhosis patients according to left ventricular volume response after dobutamine infusion (Fig. 1, 2, 3 ). The criteria of abnormal LV volume response used in this study has already been proven as an independent prognostic value for cardiac event during major vascular surgery in the department of cardiology. In conclusion, blunted cardiac response to dobutamine stimulation were frequently observed in cirrhotic patients, which may be attributed to defects in β-adrenergic receptor signalling pathways, which is one of major pathogenesis of CCM.
